Trial Profile
Treatment of Port-wine Stains by Bosentan in Addition to Pulsed Dye Laser (PDL) in Children or Young Adults Who Previously Failed to Respond to PDL Alone: a Monocentric Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2018
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Port-wine stain
- Focus Therapeutic Use
- 01 Feb 2018 Status changed from active, no longer recruiting to completed.
- 19 Dec 2014 New trial record